And Japan? [BE/BA News]

posted by ElMaestro  – Denmark, 2019-12-04 14:43 (778 d 20:43 ago) – Posting: # 20923
Views: 4,107

Wow,

» A: The guideline focuses on BCS-based biowaiver principles to be applied for bioequivalence purposes provided they are supported by a sound scientific rationale. The provision in the guideline that accommodates exceptions to existing regulations that do not permit BCS-based biowaivers for generic product applications, at this time, does not disqualify implementation of these harmonized technical requirements to demonstrate BCS based biowaivers for other product applications unless explicitly stated.

I tried to read that answer 10 times now and I am none the wiser. Do they mean "The guideline will deal with BCS-based biowaivers, but it is acknowledged that some countries might not accept those." ??
:-)

Pass or fail!
ElMaestro

Complete thread:

Activity
 Admin contact
21,833 posts in 4,568 threads, 1,554 registered users;
online 7 (0 registered, 7 guests [including 3 identified bots]).
Forum time: Friday 11:26 CET (Europe/Vienna)

No problem can stand the assault of sustained thinking.    Voltaire

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5